These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3422451)

  • 21. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
    Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
    J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
    Park JD; Kim DH
    Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
    Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
    Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of ligands to the active site of carboxypeptidase A.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5455-9. PubMed ID: 6946483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc environment and cis peptide bonds in carboxypeptidase A at 1.75-A resolution.
    Rees DC; Lewis M; Honzatko RB; Lipscomb WN; Hardman KD
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3408-12. PubMed ID: 6943549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pH on the structure and function of carboxypeptidase A: crystallographic studies.
    Shoham G; Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7767-71. PubMed ID: 6595659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for an essential histidine in carboxypeptidase Y. Reaction with the chloromethyl ketone derivative of benzyloxycarbonyl-L-phenylalanine.
    Hayashi R; Bai Y; Hata T
    J Biol Chem; 1975 Jul; 250(13):5221-6. PubMed ID: 238980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The unusual behavior of the inhibitor S(+)(1-amino-2-phenylethyl)phosphonic acid towards carboxypeptidase A.
    Bal W; Bertini I; Kozlowski H; Monnanni R; Scozzafava A; Siatecki GZ
    J Inorg Biochem; 1990 Nov; 40(3):227-35. PubMed ID: 2292683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoro ketone inhibitors of hydrolytic enzymes.
    Gelb MH; Svaren JP; Abeles RH
    Biochemistry; 1985 Apr; 24(8):1813-7. PubMed ID: 2990541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystallographic studies on apocarboxypeptidase A and the complex with glycyl-L-tyrosine.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7151-4. PubMed ID: 6580631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Benzyl-2-methylsuccinic acid as inhibitor for carboxypeptidase A. synthesis and evaluation.
    Lee M; Jin Y; Kim DH
    Bioorg Med Chem; 1999 Aug; 7(8):1755-60. PubMed ID: 10482467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic conformation of carboxypeptidase A. Structure of a true enzyme reaction intermediate determined by electron nuclear double resonance.
    Mustafi D; Makinen MW
    J Biol Chem; 1994 Feb; 269(6):4587-95. PubMed ID: 8308030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the potato inhibitor complex of carboxypeptidase A at 2.5-A resolution.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4633-7. PubMed ID: 6933511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of D-phenylalanine and D-tyrosine to carboxypeptidase A.
    Christianson DW; Mangani S; Shoham G; Lipscomb WN
    J Biol Chem; 1989 Aug; 264(22):12849-53. PubMed ID: 2568989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of carboxypeptidase A by ketones and alcohols that are isosteric with peptide substrates.
    Grobelny D; Goli UB; Galardy RE
    Biochemistry; 1985 Dec; 24(26):7612-7. PubMed ID: 4092029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of new immobilized-stabilized carboxypeptidase a derivative for production of aromatic free hydrolysates of proteins.
    Tardioli PW; Fernández-Lafuente R; Guisán JM; Giordano RL
    Biotechnol Prog; 2003; 19(2):565-74. PubMed ID: 12675602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 19F nuclear magnetic resonance spectroscopy study of the complex of 2-benzyl-4-oxo-5,5,5-trifluoropentanoic acid and carboxypeptidase A.
    Teater C; Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1988 Jun; 153(2):773-8. PubMed ID: 3382403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similarities between the conformation of arsanilazotyrosine 248 of carboxypeptidase A in the crystalline state and in solution.
    Quiocho FA; McMurray CH; Lipscomb WN
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2850-4. PubMed ID: 4507609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate-alpha-phenylalanine: optimization of methotrexate prodrug for activation by carboxypeptidase A-monoclonal antibody conjugate.
    Vitols KS; Haag-Zeino B; Baer T; Montejano YD; Huennekens FM
    Cancer Res; 1995 Feb; 55(3):478-81. PubMed ID: 7834611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel [125I]iodinated carboxypeptidase A substrate detects a metallopeptidase activity distinct from carboxypeptidase A in brain.
    Normant E; Schwartz JC; Gros C
    Neuropeptides; 1996 Feb; 30(1):13-7. PubMed ID: 8868294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.